Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Safety of SNK01 in Subjects With Pathologically Confirmed Metastatic and/or Unresectable Cancer Refractory to Conventional Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03941262
Recruitment Status : Active, not recruiting
First Posted : May 7, 2019
Last Update Posted : March 2, 2022
Information provided by (Responsible Party):
NKGen Biotech, Inc.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : August 2022
Estimated Study Completion Date : December 2022